Mechanisms Involved in Enhanced Protection Against Gram Negative Bacterium Francisella tularensis Utilizing an FcR Targeted Vaccine Platform by Babadjanova, Zulfia
Seton Hall University
eRepository @ Seton Hall
Seton Hall University Dissertations and Theses
(ETDs) Seton Hall University Dissertations and Theses
Fall 9-11-2015
Mechanisms Involved in Enhanced Protection
Against Gram Negative Bacterium Francisella
tularensis Utilizing an FcR Targeted Vaccine
Platform
Zulfia Babadjanova
zulfia.babadjanova@student.shu.edu
Follow this and additional works at: https://scholarship.shu.edu/dissertations
Part of the Biology Commons
Recommended Citation
Babadjanova, Zulfia, "Mechanisms Involved in Enhanced Protection Against Gram Negative Bacterium Francisella tularensis Utilizing
an FcR Targeted Vaccine Platform" (2015). Seton Hall University Dissertations and Theses (ETDs). 2110.
https://scholarship.shu.edu/dissertations/2110
  
 
 
 
 
 
Mechanisms Involved In Enhanced Protection Against Gram 
Negative Bacterium Francisella tularensis Utilizing An FcR 
Targeted Vaccine Platform 
    
     by 
                                Zulfia Babadjanova 
 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the requirements for the degree  
 Doctor of Philosophy 
Department of Biological Sciences  
Seton Hall University 
September 2015 
 
ii 
 
 
 
 
 
 
 
 
 
 
© 2015 Zulfia Babadjanova 
iii 
 
APPROVED BY 
 
 
Constantine Bitsaktsis, Ph.D. 
MENTOR 
 
 
 
Allan D. Blake, Ph.D.  
CO-MENTOR 
 
 
 
Heping Zhou, Ph.D. 
COMMITTEE MEMBER 
 
 
 
Daniel B. Nichols, Ph.D. 
COMMITTEE MEMBER 
 
 
 
Rico Gunawan, Ph.D. 
COMMITTEE MEMBER 
 
 
 
Allan D. Blake, Ph.D. 
DIRECTOR OF GRADUATE STUDIES 
 
 
 
Jane L. Ko, Ph.D. 
CHAIRPERSON, DEPARTMENT OF BIOLOGY DEPARMENT
iv 
 
                                     Acknowledgements 
 
 
 This research paper was made possible through the help and support of family, 
professors, and friends. I would like to take this time to formally acknowledge those who 
have made a significant contribution. 
First and foremost, I would like to thank my mentor Dr. Constantine Bitsaktsis for 
constant guidance and support throughout this amazing journey. I am truly grateful for 
his invaluable advice and knowledge, countless discussions and suggestions, and most 
importantly his patience. 
 Second, I would also like to thank the members of my thesis committee, Dr. Allan 
D. Blake, Dr. Daniel B. Nichols, Dr. Heping Zhou and Dr. Rico Gunawan for their efforts 
to review this project and provide constructive feedback. A special thanks to Kari 
Wiedinger and Heather Romlein for their assistance with my research. I also thank Dr. 
Edmund Gosselin for his scientific guidance during this research.  
I express my gratitude to my dear friends who were always there for me. Finally, I 
would like to thank my family - to my husband, two wonderful daughters, my mother and 
siblings, thank you for your support and encouragement during this endeavor.   
I dedicate this work in loving memory of my father.  
v 
 
Table of Contents 
 
 
Title Page 
 
Acknowledgement 
 
iv 
 
List of Figures 
 
vi 
 
List of Abbreviations 
 
Abstract 
 
viii 
 
ix 
 
Introduction 
 
Aims of Study  
 
1 
 
13 
 
Materials and Methods 
 
14 
 
Results 
 
21 
 
Discussion 
 
53 
 
References 
 
67 
 
vi 
 
List of Figures 
 
 
Fig. 1 Administration of mAb-iFt immune complexes reverses the anti-inflammatory 
properties of LVS in mouse PECs ex vivo 
 
Fig. 2 Immunization with mAb-iFt immune complexes increases the activation of PECs 
following LVS challenge  
 
Fig. 3 F. tularensis LPS contributes to the anti-inflammatory properties of F. tularensis 
LVS during the early stages of infection 
 
Fig. 4 Anti-inflammatory effect of F. tularensis LPS on mouse PECs is IFN-γ and IL-10 
dependent 
 
Fig. 5 Administration of mAb-iFt immune complexes reverses the anti-inflammatory 
properties of LVS in the lungs of immunized mice 
 
Fig. 6 FcγR targeting drives polarization of mouse macrophages towards the AM1 
phenotype at the early stages of LVS infection 
 
Fig. 7 Immunization of mice with mAb-iFt immune complexes enhances the number of 
CD11c+ cells in the lungs of immunized mice following F. tularensis LVS challenge 
 
Fig. 8 Increased frequency of activated CD11c+ dendritic cells in the lungs of mice 
immunized with mAb-iFt immune complexes and challenged with F. tularensis LVS 
 
Fig. 9 Immunization of mice with mAb- iFt immune complexes increases the number of 
activated CD11c
+
 lung dendritic cells following F. tularensis LVS challenge 
 
Fig. 10 Enhanced generation of effector memory CD4
+
 T cells in the spleen and lungs of 
mice immunized with mAb- iFt ICs, following F. tularensis LVS challenge 
 
Fig. 11 Targeting of iFt to FcγR provides protection against F. tularensis LVS challenge 
in an IL-12-dependant fashion 
 
Fig. 12 Generation of effector memory CD4
+
 T cells following targeting of iFt to FcγR, 
during F. tularensis LVS challenge, is IL-12-dependant 
 
Fig. 13 Immunization of mice with mAb- iFt immune complexes increases the absolute 
numbers of effector memory CD4
+
 T cells, during F.tularensis LVS infection, in an IL-
12-dependant fashion 
 
vii 
 
Fig. 14 Increased generation of IFN-γ producing effector CD4+ T cells in mice 
immunized with mAb- iFt IC compared to mice immunized with iFt alone 
viii 
 
List of Abbreviations 
 
 
LVS   Live vaccine strain 
iFt  inactivated Francisella tularensis  
APC  Antigen presenting cell 
PEC  Peritoneal exudate cell 
SPC  Splenocyte 
CFU  Colony forming unit 
MOI  Multiplicity of infection 
LPS  Lipopolysaccharide 
TLR  Toll like receptor 
IC  immune complex 
mAb  monoclonal antibody 
IFN-γ  Interferon gamma 
IL-12  Interleukin 12 
IL-10  Interleukin 10 
TNF-α  Tumor necrosis factor alpha 
PBS  Phosphate buffered saline 
IgG  Immunoglobulin G 
FcγR  Fc gamma receptor 
MHC  Major Histocompatibility Complex 
AM1  Classically activated macrophages 
AM2  Alternatively activated macrophages 
CD80  Cluster of differentiation 80 
CD86  Cluster of differentiation 86 
Th1  Type I T helper cells 
Th2  Type II T helper cells 
ix 
 
Abstract 
 
 
 Francisella tularensis is a gram-negative intracellular bacterium and the etiologic 
factor of a potentially fatal disease tularemia.  Due to its high infectivity the Centers for 
Disease Control and Prevention has designated F. tularensis as a Category A biological 
agent.  Nevertheless, the pathogenesis of F. tularensis is not fully understood and 
research has failed to develop an effective vaccine.  
Production of pro-inflammatory cytokines by innate immune cells at the early 
stages of bacterial infection is important for host protection against the pathogen.  Many 
intracellular bacteria, including F. tularensis, utilize the anti-inflammatory cytokine IL-
10, to evade the host immune response.  It is well established that IL-10 has the ability to 
inhibit robust antigen presentation by dendritic cells and macrophages, thus suppressing 
the generation of protective immunity.  
 In the current study, it is hypothesized that F. tularensis polarizes antigen 
presenting cells during the early stages of infection towards an anti-inflammatory status 
characterized by increased synthesis of IL-10, and decreased production of IL-12p70 and 
TNF-α in an IFN-γ-dependent fashion.  In addition, F. tularensis drives an alternative 
activation of alveolar macrophages within the first 48 hours post-infection, thus allowing 
the bacterium to avoid protective immunity.  
 Furthermore, for the first time, this study demonstrates that targeting inactivated 
F. tularensis (iFt) to Fcγ receptors (FcγRs) via intranasal immunization with mAb-iFt 
complexes reverses the anti-inflammatory effects of the bacterium on macrophages by 
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down-regulating production of IL-10 and mediates generation of F. tularensis-specific, 
IFN-γ secreting effector memory CD4+ T cells.  Furthermore, targeting of iFt to FcγRs 
enhances the classical activation of macrophages not only within the respiratory mucosa, 
but also, systemically, at the early stages of infection.  These results provide important 
insight for further understanding the protective immune mechanisms generated when 
targeting immunogens to Fcγ receptors validating its potential as a universal vaccine 
platform against mucosal pathogens.  
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Introduction 
 
 
Francisella Tularensis 
 
Tularemia is a zoonotic infection characterized by onset of flu-like symptoms 
including fever, chills, headache and enlargement of lymph nodes.  The causative agent 
of tularemia is Francisella tularensis, a gram-negative facultative intracellular bacterium 
that was first described in the literature in 1912 by McCoy and Chapin, as a bacterial 
pathogen that caused a plaque-like disease in rodents in Tulare County, California 
(McCoy & Chapin, 1912).  The bacterium was initially named Bacterium tularensis but 
was later re-named Francisella tularensis to honor a researcher Edward Francis, who 
extensively studied the pathogen.   F. tularensis can be transmitted through insect bites, 
infected carcasses, contaminated water, and inhalation of contaminated air, although 
inhalation of as little as 1-2 bacteria can lead to respiratory failure and death if left 
untreated (Ellis et al., 2002; Metzger et al., 2007; Sjostedt et al., 2007; Oyston et al., 
2008).  For this reason, the Centers for Disease Control and Prevention has designated F. 
tularensis as a Category A biological agent (Rotz et al., 2002).  In fact, The World Health 
Organization (1970) predicted that an intentional spread of virulent F. tularensis over a 
metropolitan area would lead to 250,000 cases of infection including 19,000 lethal 
outcomes.  
There are four subspecies of F. tularensis: novicida, holarctica, mediasiatica and 
the most virulent subspecies tularensis that has only been found in North America (Cole 
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et al., 2011).  One of the properties of F. tularensis is its ability to survive and proliferate 
within phagocytic cells of the host.  Upon the uptake into the host cell through 
phagocytosis, F. tularensis undergoes interaction with early and late endosomes after 
which a rupturing of the phagosomal membrane allows bacterium release into a cytosol 
(Santic et al., 2005; Chong et al., 2010; Geier et al., 2011).  In the cytosol of non-
activated cells the bacteria proliferates rapidly leading to apoptosis of the infected cells 
(Sjostedt, 2007).  Thus, F. tularensis can evade a critical arm of the innate immune 
response by escaping from the phagolysosome pathway of myeloid cells.  Another 
mechanism by which F. tularensis alters host cell immunity is increased synthesis of 
prostaglandin E2 (PGE2) (Woolard et al., 2007).  PGE2 is a potent regulator of the 
immune response by skewing it towards an overwhelming Th2 response and subsequent 
inhibition of T cell proliferation as opposed to generation of protective Th1 response. 
Several studies reported that early innate immune responses, in particular 
secretion of inflammatory cytokines such as TNF-α, IFN-γ and IL-12, provide immediate 
control over F. tularensis replication (Leiby et al., 1992; Elkins et al., 2003; Duckett et al. 
2005).  F. tularensis infection, however, is characterized by the absence of early immune 
responses throughout the first 2-3 days after infection (Bosio et al., 2007; Rawool et al., 
2008; Singh et al., 2013).  This is believed to occur partly because of the low 
endotoxicity of F. tularensis lipopolysaccharide (LPS), which is structurally different 
from other Gram-negative bacterial LPS (Ancuta et al., 1996; Barker et al., 2006; Duenas 
et al., 2006; Hajjar et al., 2006).  One of the differences is the lack of a phosphate at 4' 
position on lipid component A, another difference is that F. tularensis lipid A is tetra-
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acylated and contains longer acyl chains of 16 to 18 carbons (Hajjar et al., 2006).  These 
structural modifications interfere with the binding of LPS to a toll-like receptor 4-
myeloid differentiation factor 2 (TLR4-MD2) complexes on host pattern recognition 
receptors, preventing the TLR4 oligomerization and activation of signaling, therefore, 
enabling F. tularensis to better evade the immune response.  
 
Francisella Tularensis Vaccine 
 
Since no licensed vaccine for tularemia is currently available in the United States 
and around the world, there is a need for development of an effective vaccine.  
Different approaches have been explored to identify routes of protection against 
lethal challenge with virulent type of F. tularensis, including whole bacteria and subunit 
vaccines.  For instance, a vaccine developed by Foshay in 1940’s, consisted of a whole F. 
tularensis bacteria killed through acetone extraction followed by phenol preservation.  
This vaccine was regarded as a safe formulation and was tested in animal models as well 
as administered to a large number of human volunteers.  However, the results obtained 
from these studies did not show enough efficacies in protection against virulent strains of 
F. tularensis (Foshay et al., 1942).   Furthermore, studies performed in the former Soviet 
Union using live attenuated strain of F. tularensis subspecies holarctica demonstrated 
more effectiveness in providing protection against bacterial challenge in comparison to 
Foshay vaccine.  This vaccine was granted an investigational new drug status by the US 
Food and Drug Administration (FDA) and was named Live Vaccine Strain (LVS).  Even 
though, the use of this vaccine generated quite promising results, the cause of its 
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attenuation is still unknown and consequently, LVS has not been approved by FDA for 
human administration (Conlan, 2004; Barry et al., 2009; Pechous et al., 2009; Schmitt et 
al., 2013).  While attenuated in humans, LVS is highly virulent in rodents and therefore, 
is widely used in animal models to further understand the pathogenesis of tularemia.   
Several studies have also investigated antigenic proteins on the bacterial surface 
such as LPS and outer membrane proteins (OMP) to assess their ability to trigger the 
protective immune response and to be further utilized for development of subunit 
vaccines against F. tularensis infection.  Despite generating a protective antibody 
response to challenge with less virulent subspecies of F. tularensis, the subunit vaccines 
did not show significant efficacy to challenge with most virulent subspecies of the 
bacteria.  Given that F. tularensis is an intracellular pathogen, the activation of both 
humoral and cell-mediated immunity might be required for stimulation of a sufficient 
immune response.  Therefore, the search for safe and effective vaccine against infectious 
tularemia is still ongoing and various vaccine platforms are currently being evaluated.   
 
Fcγ Receptor Targeting: Overview 
 
Previous studies have shown that targeting antigens to Fc receptors (FcR) on 
antigen presenting cells (APCs) leads to enhancement of innate and adaptive immunity 
(Gosselin et al., 1992; Rawool et al., 2008; Gosselin et al., 2009; Bitsaktsis et al., 2012; 
Iglesias et al., 2012).  Fcγ receptors are proteins on the surface of cells such as natural 
killer cells, macrophages, dendritic cells, neutrophils and mast cells.  There are four 
classes of Fcγ receptors currently known in mice: FcγRI, FcγRII, FcγRIII and FcγRIV.  
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The first three classes of Fcγ receptors are highly homologous to the human Fcγ 
receptors.  Structurally Fcγ receptors have similar extracellular domain, while the 
transmembrane and cytoplasmic domains are different (Gessner et al., 1998).  
Functionally, the Fcγ receptors differ by their affinities to their ligands and by signaling 
they initiate (Ravetch & Kinet, 1991; Nimmerjahn & Ravetch, 2007).  The Fcγ receptors 
that stimulate cell activation, FcγRI, FcγRIII and FcγRIV, consist of an immunoglobulin 
binding α-chain and γ-chain containing signaling motif immunoreceptor tyrosine-based 
activation motif (ITAM).  On the other hand, the only inhibitory FcγRIIB receptor 
contains α-chain and the immunoreceptor tyrosine-based inhibition motif (ITIM) 
(Daeron, 1997; Platzer et al., 2014).  All FcγRs bind with different affinities and 
specificities to various subclasses of immunoglobulin G (IgG).  Yet, FcγRI is the only 
activating receptor that binds to IgGs, in particular IgG1 and IgG3 in humans, and IgG2b 
in mice, with significantly higher affinity compared to other FcγRs (Gosselin et al., 
2009).  There are four IgG subclasses in humans (IgG1, IgG2, IgG3 and IgG4) and mice 
(IgG1, IgG2a, IgG2b and IgG3).  
One of the characteristics of the activating Fcγ receptors is their ability to 
phagocytose antibody-antigen complexes and further facilitate presentation of processed 
antigenic peptides on MHC class I and MHC class II molecules to T cells (Regnault et 
al., 1999; Nimmerjahn & Ravetch, 2007).  It is believed that these immune complexes 
(ICs) bind to Fcγ receptors via Fc region of antibodies leading to cross-linking of the 
receptors and subsequent uptake of the ICs.  However, Igleasias et al. (2012) observed 
that the increase in the FcγR mediated antigen presentation required a physical linkage 
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between the mAb and antigen indicating that receptor cross-linking by itself is not 
sufficient for enhanced antigen presentation.  The phagocytized antigens are then directed 
to the intracellular antigen presentation compartments (Baker et al., 2014; Platzer et al., 
2014).  Some studies suggest that the efficient intracellular transport of ICs is mediated 
by the neonatal Fc receptor (FcRn), an intracellular receptor expressed within antigen 
presenting cells that binds to IgG only under acidic conditions of endocytic vacuoles 
(Bitsaktsis et al., 2012; Baker et al., 2014; Guilliams et al., 2014).  
It has been previously demonstrated that targeting inactivated F. tularensis (iFt) 
bacteria to the FcγRs in mice, via immunization with mAb-iFt immune complexes, 
resulted in: (1) enhanced uptake and presentation of the immunogen (iFt) by professional 
antigen presenting cells, (2) increased activation and maturation of dendritic cells, (3) 
enhanced F. tularensis-specific cytokine and antibody responses, and  (4) increased 
protection against F. tularensis infection (Rawool et al., 2008; Iglesias et al., 2012).  This 
protection was FcγR and FcRn dependent, as immunization of either FcγR or FcRn 
deficient mice as well as administration of F(ab’)2 mAb-iFt immune complexes 
abrogated protection (Rawool et al,. 2008).  In addition, it has been shown that targeting 
the pneumococcal surface protein A (PspA) to human FcRI in FcRI transgenic mouse 
model, also elicited enhanced protection against Streptococcus pneumoniae challenge 
(Bitsaktsis et al., 2012).  Therefore, utilization of FcγR targeted approach provides a great 
potential for development of an effective vaccine strategy against tularemia.  
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Immune responses during F. tularensis infection 
 
For many intracellular bacteria the induction of a robust innate immune response 
is a critical factor in host protection and bacterial clearance (Medzhitov & Janeway, 
1997; Pashine et al., 2005; Kalinski, 2012).  The induction of innate immunity is 
triggered upon recognition of bacterial components such as lipopolysaccharides, 
peptidoglycans, or bacterial DNA by cellular receptors in the early phases of infection 
and regulated by a number of pro-inflammatory cytokines including IL-12, TNF-α and 
IFN-γ and co-stimulatory molecules.  Activation of the innate immune system, in turn, 
leads to initiation of more complex pathogen-specific adaptive immune responses 
responsible for bacterial elimination in the late phases of infection (Alfano & Poli, 2005; 
Lacy & Stow, 2011).  However, as previously mentioned the F. tularensis infection lacks 
the early immune responses throughout the first 2-3 days after infection (Bosio et al., 
2007; Rawool et al., 2008; Singh et al., 2013).   
Interleukin-10 (IL-10), an anti-inflammatory cytokine secreted by many different 
cell populations including T cells, B cells, macrophages, dendritic cells and keratinocytes 
(Shibata et al., 1998; Pestka et al., 2004), inhibits pro-inflammatory cytokine synthesis 
and the antigen presenting ability of monocytes/macrophages and dendritic cells 
(Asadullah et al., 2003).  A number of studies have demonstrated that many intracellular 
pathogens, such as F. tularensis, use IL-10 to evade the host immune defense especially 
in the initial stages of infection (Abrahamsohn & Coffman, 1996; Salek-Ardakani et al., 
2002; Sing et al., 2002; Metzger et al., 2013).   
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The anti-inflammatory cytokine IL-10 is one of the key suppressors of host 
immune system that inhibits the antigen presentation ability of macrophages and 
dendritic cells mainly by down-regulating the expression of CD80, CD86 and MHC class 
II molecules, as well as the production of pro-inflammatory cytokines (Pestka et al., 
2004).  The ability of IL-10 to suppress innate, inflammatory responses against 
intracellular pathogens has been previously reported.  For instance, lack of endogenous 
IL-10 production led to a decrease in number of Trypanosoma cruzi parasites in the blood 
of infected mice and increase in production of IFN-γ and nitric oxide (NO), which were 
reversed after administration of rIL-10 (Abrahamsohn et al., 1996).  Similarly, lack of IL-
10 resulted in higher resistance of mice to Listeria monocytogenes, characterized by 
lower bacterial burden, decreased tissue damage and increased pro-inflammatory 
cytokine response (Dai et al., 1997).  Furthermore, the V antigen of Yersinia pestis 
caused suppression of the Th1 cytokine TNF-α in mouse and human macrophages by 
increasing IL-10 synthesis. In the same study, IL-10 deficient mice were highly resistant 
to the infection in comparison to wild type (Sing A. et al., 2002).  In addition, viruses 
have also evolved mechanisms to escape the immune response by altering the Th1/Th2 
balance.  It has been shown that Epstein-Barr virus (EBV) utilizes the viral IL-10 (vIL-
10), which is 84% identical in amino acid sequence to the human IL-10, to regulate the 
host immune response.  Production of vIL-10 by EBV leads to inhibition of IFN-γ 
synthesis which is important for early regulation of EBV infection (Salek-Ardakani et al., 
2002).  Elevated levels of IL-10 which correlated with higher viral load in HIV infected 
individuals were observed by Brockman et al. (2009).  However, inhibition of IL-10 
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pathway increased synthesis of pro-inflammatory cytokines IFN-γ and IL-2 reversing the 
suppression of virus-specific T cell functions that play a key role in controlling HIV 
infection (Brockman et al., 2009).  
IL-10 has also been identified as a key regulator of immune response to F. 
tularensis infection.  In particular, IL-10 mediates suppression of IL-17 production in F. 
tularensis LVS infected mice (Metzger et al., 2013).  IL-17, in turn, is believed to play a 
protective role in the initiation of cellular immune response to F. tularensis LVS 
infection by induction of IL-12 and IFN-γ production (Lin et al., 2009).  Several studies 
have demonstrated that blockade of TNF-α, IFN-γ and IL-12 signaling pathways 
decreases the survival rate in murine model during F. tularensis LVS infection (Leiby et 
al., 1992; Duckett et al., 2005).  These cytokines activate production of nitric oxide in 
macrophages, which leads to the F.tularensis LVS bacterial killing by causing the 
double-stranded DNA breakage, bacterial Fe
2+
 release and depletion of antioxidant 
glutathione (Chakravortty et al., 2003; Lindgren et al., 2005).  
 F. tularensis predominantly infects antigen presenting cells such as macrophages 
and dendritic cells, the primary components of host defense mechanism.  Therefore, 
activation of these cells plays an important role in controlling the replication of F. 
tularensis.  Depending on the extracellular cytokine background, the activated 
macrophages are divided into two distinct groups, classically activated macrophages 
(AM1) associated with high levels of pro-inflammatory cytokines and alternatively 
activated macrophages (AM2) characterized by increased levels of anti-inflammatory 
cytokines, in particular IL-10 (Benoit et al., 2008).  In addition to a distinct cytokine and 
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chemokine milieu, polarized macrophages portray different receptor expression (Mosser, 
2003; Mantovani et al., 2004; Badylak et al., 2008; Benoit et al., 2008; Tomioka et al., 
2012; Jaguin et al., 2013).  Thus, CCR7, B7.1 (CD80), B7.2 (CD86) and MHCII have 
been identified as reliable surface markers that are up-regulated in classically activated 
macrophages.  On the other hand, numerous studies have reported up-regulation of FIZZ-
1 and Arg-1 in alternatively activated macrophages during infection, cancer and 
inflammatory conditions such as atherosclerosis (Raes et al., 2002; Benoit et al., 2008; 
Meghari et al., 2008; Ishii et al., 2009;  Porta et al., 2009; Sanson et al., 2013).  
Classically activated macrophages are critical in control of replication of intracellular 
bacteria and therefore, required for host’s defense against various infections (Katakura et 
al., 2004; Benoit et al., 2008; Shaughnessy et al., 2010).  It has been previously proposed 
that one of the mechanisms that F. tularensis utilizes to subdue the protective immune 
response is its ability to induce the activation of alternatively activated macrophages to 
inhibit the protective M1 activation (Shirey et al., 2008).   
 
Generation of Memory T cells 
 
 One of the main goals of vaccine strategy is the induction of a long-lasting 
protective memory. The properly activated antigen presenting cells play an important role 
in activation of pathogen-specific adaptive immunity (Beverley, 2002).  The generation 
of a T-cell memory, in particular, is essential to long lasting protective immunity which 
consists of T helper lymphocytes or CD4
+
 and killer T lymphocytes or CD8
+
.  In 
addition, there are two types of T memory cells, effector memory (TEM) and central 
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memory (TCM) cells that differ based on their functional responses as well as the 
expression of CD62L and CCR7 cell surface markers.  Specifically, TCM cells migrate to 
lymphoid tissues where they stimulate dendritic cells and induce a new generation of the 
effector T cells.  On the other hand, TEM cells are located largely in peripheral tissues 
where they activate a protective immune response against infectious pathogens including 
elevated production of inflammatory cytokines such as IFN-γ.  Furthermore, TCM cells 
express adhesion molecule CD62L and chemokine receptor CCR7 that are critical for T 
cell migration to lymph nodes, while TEM cells are negative for both receptors (Gunn et 
al., 1998; Sallusto et al., 1999; Campbell & Butcher, 2000; Esser et al., 2003; McKinstry 
et al., 2010).  
  Polarization of T cells, regulated by antigen presenting cells via interaction with 
T cell receptor, is an important attribute of immune responses.  There are three main 
subtypes of CD4
+
 T cells that differ based on the secreted cytokine milieu – Th type 1 
(Th-1), Th type 2 (Th-2) and Th type 17 (Th-17) cells (Sattler et al., 2009).  Th-1 cells 
secrete pro-inflammatory cytokines such as IFN-γ and TNF-β that provide an effective 
cell-mediated response against intracellular pathogens.  Th-2 cells secrete anti-
inflammatory cytokines including IL-4 and IL-10 that trigger antibody-mediated 
response.  Finally, Th-17 cells secrete cytokines such as IL-17, IL-17F and IL-22 that 
contribute to generation of protection against extracellular pathogens (Esser et al., 2002; 
Kaiko et al., 2007).  T cell polarization largely depends on cytokines released by 
activated APCs and is triggered upon binding of these cytokines to their respective 
receptors on the surface of T cells.  For instance, it has been previously shown that IL-12, 
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a heterodimeric cytokine produced by APCs in response to intracellular pathogens, is 
required for development of IFN-γ producing Th-1 cells.  Moreover, the two cytokines 
act in an autocrine manner amplifying the Th-1 polarization and subsequently enhancing 
generation of an immune response (Macatonia et al., 1995; Schroder et al., 2004).  
Although cell mediated responses are critical to generation of long term immunity against 
intracellular infection, it has been shown previously that F. tularensis skews the T cell 
response from pro-inflammatory Th-1 towards anti-inflammatory Th-2 response, leading 
to inhibition of T cell activation (Woolard et al., 2007).  Therefore, further understanding 
of the mechanisms utilized by F. tularensis to evade host immune responses will help for 
development of an effective vaccine against tularemia.  
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
Aims of the study 
 
 
1. To characterize the inflammatory responses in mice during early phase of F. 
tularensis infection 
  In the current study we hypothesized that F. tularensis polarizes antigen 
presenting cells (APCs) during the first 48 hours post-infection towards an anti-
inflammatory status, characterized by IL-10 production, thus allowing the pathogen to 
avoid protective anti-bacterial innate immune responses.  
2. To characterize the immune responses in mice upon delivery of immune 
complexes to Fcγ receptors during early phase of F. tularensis infection 
We seek to determine whether targeting of mAb-iFt immune complexes to FcγRs 
reverses the potential detrimental role of IL-10 during the early stages of Francisella 
infection.  
3. To characterize the effect of Fcγ targeted mucosal vaccination on dendritic cell 
activation and memory CD4
+
 T cell formation in vivo during lethal challenge 
with F. tularensis LVS 
It has been previously shown that targeting immune complexes to Fcγ receptors 
stimulates dendritic cell activation and maturation leading to enhanced iFt presentation to 
T cells in vitro (Iglesias et al. 2012).  Nevertheless, questions remain regarding the in vivo 
impact of mAb-iFt immunization and whether DC activation and T cell priming also 
occur in vivo when utilizing the FcγR targeted vaccine strategy. 
14 
 
Materials and Methods 
 
 
Mice and bacteria:  
C57BL/6, IL-10 genetically deficient and IL-12p35 genetically deficient mice 
were purchased from Jackson Laboratories (Bar Harbor, Maine).  All mice were housed 
at the Animal Research Facility at Seton Hall University.  The mice were used at 6-10 
weeks of age.  All protocols were reviewed and approved by the Seton Hall University 
Ethics Committee utilizing NIH standards.  Mouse anesthesia was performed via i.p. 
injections of a ketamine/xylazine cocktail, while mouse euthanasia was achieved via CO2 
administration followed by cervical dislocation. 
F. tularensis LVS (ATCC 29684; American Type Culture Collection) was 
provided by K. Elkins (U.S. Food and Drug Administration, Bethesda, MD).  
 
Antibodies:  
Mouse IgG2a anti-Ft. LPS mAb used to generate mAb-iFt immune complexes 
was purchased from Fitzgerald (Cat# 10-F02, clone#M023621, Acton, MA).  The 
following flow cytometry antibodies were purchased from BD Biosciences (San Jose, 
California): F4/80 (PE), anti-CD3 (FITC), anti-CD4 (APC), anti-CD44 (PE), anti-CD62L 
(PercP Cy 5.5), anti-CD11b (FITC),  anti-CD11c (APC), anti-IFNγ (PE),  anti-DEC-205 
(PercP Cy 5.5), anti-CCR7 (PE-Cy7), anti-CCR7 (PE-Cy5.5), MHC class II (APC), B7.1 
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and B7.2 (PercP).  For neutralizing IL-12p35 in vivo, the rat IgG2a anti-mIL12 (clone: 
C18.2) and its isotype control were purchased from eBioscience (San Diego, CA).  
 
Inactivation and Labeling of F. tularensis:  
Inactivated F. tularensis LVS (iFt) was generated by growing F. tularensis LVS 
in Mueller Hinton broth (MHB) media (BD Biosciences) up to a density of 1x10
9 
CFU/mL.  The culture was then spun down at 22,000g for 20 minutes at 4
o
C, and washed 
3 times with PBS, resuspended in 2% Paraformaldehyde (PFA) (Sigma) and incubated 
for 2 hours at room temperature on a rocker.  Bacteria were then washed 3 more times 
with PBS and 1x10
9 
organisms were plated on a chocolate agar plate (BD Biosciences) 
and incubated for 7 days at 37°C to confirm inactivation.  The final concentration of iFt 
organisms was determined by OD at 610 nm. 
 
mAb-iFt Immune Complex (IC) Generation:  
To generate ICs, 1x10
9
 iFt organisms were incubated at 4
°
C overnight on a rocker 
with 0 µg/mL or 1µg/mL of mAb-iFt or anti-iFt F(ab’)2 in PBS.  Following incubation, 
iFt, mAb-iFt or F(ab’)2-iFt preparations were washed once with PBS to remove any 
unbound antibody and administered to mice intranasally.  Generation of ICs has been 
previously confirmed by ELISA and SDS-PAGE (Rawool et al., 2008; Iglesias et al., 
2012).   
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Immunization and Challenge Studies:  
C57BL/6, IL-10 deficient and IL-12p35 deficient mice were divided into three 
groups consisting of 5-6 mice/group, 6-10 weeks or 8-12 weeks of age.  Each mouse was 
immunized on days 0 and 21 with 2x10
7
 iFt organisms alone or in the form of mAb plus 
iFt ICs.  On day 35 the mice were challenged with 10,000 CFU of live F. tularensis LVS. 
Following challenge survival was monitored twice-daily for 21-25 days.  Death, due to 
the infection, was considered as the experimental end-point, although, in the occasions 
were animals deemed to suffer (i.e. completely immobile, hunched backs, eyes shut), 
mice were sacrificed via CO2 administration followed by cervical dislocation, per our 
approved animal protocol (Approval # CB1401).  Exact CFU administered were also 
verified by culturing and counting the inoculum subsequent to challenge on chocolate 
agar plate.  
 
Lung leukocyte isolation:  
Lungs of immunized mice were harvested 24, 48 and 96 hours post-infection, 
perfused with cold 1x PBS containing a protease inhibitor cocktail, shredded into small 
pieces, and placed in digestion buffer containing RPMI (Life Technologies), 0.2mg/mL 
DNaseI (Sigma), 0.4mg/mL Collagenase D (Sigma), and 1M MgCl2.  After a 30 minute 
incubation at 37
o
C the digested tissue samples were forced through a cell strainer and the 
cell suspension obtained was washed and resuspended in RPMI containing 2% FBS.  The 
cell suspension was then carefully layered on 5 mLs of Lympholyte M (Cedarlane 
Laboratories, Burlington, NC), and spun down at 15,000g for 30 minutes at room 
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temperature.  Following centrifugation, the interface containing the majority of immune 
cells was obtained and added in RPMI with 2% FBS prior to enumeration.  Identification 
and enumeration of alveolar macrophages was based on the expression of surface 
antigens F4/80 and CD11b.  In case of DCs isolation, lung leukocytes were cultured in 
petri dishes containing complete medium at 2x10
6
 cells/mL for 1 hour at 37°C.  
Identification and enumeration of DCs was based on the expression of CD11c and DEC-
205.  These markers are primarily expressed on mouse DCs (Kronin et al., 2000; Bonifaz 
et al., 2004).  Nevertheless, a small percentage of alveolar macrophages (3-4%) are also 
positive for these markers (Higgins et al., 2008).  Therefore, in order to further increase 
DC purity, lung white blood cells were cultured for 30 minutes at 37°C in petri dishes to 
remove (via adherence) the lung macrophages.  
 
Peritoneal exudate cell (PEC) isolation:  
PECs were harvested 48 hours post-infection, centrifuged in a refrigerated 
centrifuge 4,000g for 10 minutes.  Following centrifugation, the interface containing 
PECs was resuspended in RPMI with 10% FBS, prior to enumeration.  Identification and 
enumeration of PECs was based on the expression of surface antigens F4/80. 
 
Neutralization of IL-12 in vivo:  
Two doses of rat anti-murine anti-IL-12p35 mAb (C18.2) were administered 
intraperitoneally (i.p.) (500μg in 250μl of PBS) on days -1, 0 and 1 post-LVS infection.  
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This method has been proven to neutralize IL-12 in vivo for a minimum of five days post-
administration of the IL-12p35 mAb (Meyts et al., 2006). 
Flow cytometry:  
Peritoneal exudate cells, lung parenchymal cells or splenocytes were obtained 
from immunized mice at different time-points post-F. tularensis LVS infection as 
described above.  For cell surface marker staining, cells were washed with PBS-BSA-
azide, resuspended in blocking buffer [PBS-BSA-azide plus 30 µg/mL of normal mouse 
IgG (Sigma)] and incubated on ice for 30 minutes.  Cells were then washed with PBS-
BSA-azide and fluorescently labeled antibodies to CD11b, CD11c, F4/80, DEC-205, 
MHC class II, B7.1, B7.2, CCR7, CD3, CD4, CD44, CD62L or their corresponding 
isotype controls were added.  The cells were then incubated on ice for 30 minutes, 
washed, and then fixed with 2% paraformaldehyde (PFA).  Cells were then analyzed by 
flow cytometry on an LSRII flow cytometer (BD Biosciences). 
 
Intracellular cytokine staining:  
Splenocytes (SPCs) from immunized mice were obtained 2 days post-LVS 
infection and cultured for 5 hours at 37
o
C in the absence or presence of LVS (1x10
3
 
CFUs per 2x10
5
 SPCs).  For a positive control, SPCs were cultured in complete media 
(RPMI, 2% FBS, L-glutamine), with 50ng/mL PMA (Sigma) and 500ng/mL ionomycin 
(Sigma).  Cell media also contained protein transport inhibitor with 10 μg/mL of 
Brefeldin A (GolgiPlug – BD Biosciences).  Following incubation, the cells were washed 
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with PBS-BSA-azide (containing the protein transport inhibitor), resuspended in blocking 
buffer, and stained with the cell surface marker antibodies for CD3, CD4, and CD44, and 
fixed with 2% PFA as described above. 
After fixation, cells were washed, resuspended, and incubated in permeabilization 
buffer (BD Biosciences) for 15 minutes at 4
o
C to facilitate pore formation.  Anti-mIFN- 
was diluted in permeabilization buffer and added to each cell sample.  Cells were further 
incubated on ice for 30 minutes.  Following incubation, cells were washed, resuspended 
in PBS-BSA-azide, and analyzed by flow cytometry on an LSRII flow cytometer (BD 
Biosciences).  For intracellular cytokine staining of lung DCs, the latter cells were 
obtained from immunized mice, as previously described, 2 days post-LVS challenge. 
DCs were stained for the cell surface markers: DEC-205 and CD11, and intracellularly 
for IL-12, as described above.  The results were analyzed by flow cytometry on an LSRII 
flow cytometer (BD Biosciences). 
 
Cytokine measurements:  
C57BL/6 mice were immunized intranasally (i.n) with PBS, iFt (1x10
9
 CFUs), or 
mAb-iFt, boosted on day 21 and challenged on day 35 with either 10,000 CFUs or 20,000 
CFUs of F. tularensis LVS.  After 48 hours post-infection peritoneal cells  or lung DCs 
were obtained from all groups and cultured for 24 or 48 hours with either F. tularensis 
LVS (1:10 and 1:100 MOI or 1x10
3
 CFUs/well), F.tularensis LPS (kindly provided by 
Dr. Timothy Sellati – Albany Medical College, Albany, NY) or E. coli-LPS (Sigma) at 1 
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ng/mL, 10 ng/mL and 20 ng/ml, or recombinant IFN-γ (Invitrogen) at 100 U/mL.  
Supernatants were collected at designated time points and the levels of IL-12p70, TNF-α 
and IL-10 cytokines were measured using BD Biosciences Cytometric Bead Array 
(CBA) following vendor instructions. 
In a separate experiment, lung tissue (left lobe) was harvested from immunized 
mice and homogenized (Omni Homogenizer, Omni International, GA).  Homogenates 
were then spun down at 15,000g for 30 minutes at room temperature to remove tissue 
debris and cytokine levels were detected by using the IL-6, IL-10, TNF-α and IFN-γ 
ELISA kits by following vendor instructions (Biolegend).   
 
Statistical Analysis:   
The Log-Rank (Mantel-Cox) test was used for survival curves.  Statistical 
differences among the groups were analyzed using a one-way analysis of variance 
(ANOVA) or the unpaired, one-tailed student t-test.  GraphPad Prism 4 provided the 
software for the statistical analysis (San Diego, CA). 
 
 
 
 
 
 
 
 
 
21 
 
Results 
 
 
Administration of mAb-iFt immune complexes (ICs) reverses the anti-inflammatory 
properties of F. tularensis LVS ex vivo and increases the activation of mouse 
peritoneal exudate cells (PECs) 
One of the critical immune responses to bacterial infection is the synthesis and 
release of pro-inflammatory cytokines by innate immune cells during the early stages of 
infection (Medzhitov & Janeway, 1997; Pashine et al., 2005; Kalinski, 2012).  Given the 
ability of F. tularensis to evade the immune system by favoring the short-term secretion 
of anti-inflammatory cytokines (Bosio, 2011; Metzger et al., 2013), it was of interest to 
investigate the cytokine levels produced by PECs at the early stages of infection.  
Therefore, production levels of inflammatory cytokines IL-12p70 and TNF-α as well as 
the anti-inflammatory cytokine IL-10 were analyzed using PECs from immunized and 
subsequently challenged mice.  On day 35 post-immunization mice were challenged with 
10,000 CFU of live F. tularensis LVS and cells were isolated two days post-infection. 
PECs were further stimulated with F. tularensis LVS ex vivo (at 1:10 and 1:100 MOI) for 
24 hours and the cytokine levels in the supernatant were measured by the BD Biosciences 
Cytometric Bead Array (CBA).  The levels of IL-12p70 (Fig.1A) and TNF-α (Fig. 1B) in 
supernatants from PECs of mAb-iFt immunized mice were significantly higher (two to 
three fold) in comparison to mice immunized with iFt alone.  By contrast, the levels of 
IL-10 production were 2-fold lower in the mAb-iFt compared to mice immunized with 
iFt alone (Fig. 1C) independent of the MOI tested.  
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Fig.1 Administration of mAb-iFt immune complexes reverses the anti-inflammatory 
properties of LVS in mouse PECs ex vivo 
C57BL/6 mice (n=6 for each group) were immunized i.n. with PBS, iFt (2x10
7
 CFUs), or 
mAb-iFt, boosted on day 21 and challenged on day 35 with 10,000 CFUs of Ft LVS. 
After 48 hours after F. tularensis LVS challenge, the PECs of immunized mice were 
harvested and cultured in the presence or absence of F. tularensis LVS at 1:10 and 1:100 
MOI for 24 hrs. The cytokine production was measured as previously described. Results 
shown are mean ± SD from three independent experiments determined by one-way 
ANOVA (* P-value ˂ 0.1; ** P-value ˂ 0.05). 
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IL-10 is known to decrease the cell surface expression of MHC class II and co-
stimulatory molecules CD80 and CD86 on murine macrophages (Ding et al., 1993).  
However, one of the mechanisms by which immune complexes trigger immune responses 
is via T cell activation that requires robust antigen presentation by activated antigen 
presenting cells and increased expression of co-stimulatory molecules.  Previous 
experiments have shown that co-culturing of F.tularensis- specific T cell hybridoma with 
mouse PECs in the presence of mAb-iFt noticeably increased F.tularensis-specific T cell 
responses compared to using the iFt immunogen alone (Iglesias et al., 2012).  Therefore, 
the hypothesis was that targeting of immunogen to Fcγ receptors (FcγRs) increases 
systemically the activation status of antigen presenting cells following F. tularensis LVS 
challenge.  Thus, the expression of MHC class II and co-stimulatory molecules CD80 and 
CD86 were measured on PECs from immunized mice post-infection. 
 Peritoneal cells were obtained from immunized mice two days after F. tularensis 
LVS challenge as described in Materials and Methods, and the expression of the murine 
macrophage cell-surface marker F4/80, the co-stimulatory molecules CD80 and CD86, as 
well as MHC class II was determined by flow cytometry.  Although the number of cells 
expressing the F4/80 cell surface marker was similar between the iFt and mAb-iFt 
immunized mice, the number and frequency of cells expressing both MHC class II and 
CD80/CD86 molecules was significantly increased in the mAb-iFt group (Fig. 2).  This 
enhancement in surface marker expression upon immunization with mAb-iFt correlates 
with the increased presentation of iFt in the presence of mAb-iFt in vitro (Iglesias et al., 
2012).   
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Fig. 2: Immunization with mAb-iFt immune complexes increases the activation of 
PECs following LVS challenge  
C57BL/6 mice (n=6 for each group) were immunized i.n. with PBS, iFt (2x10
7
 CFUs), or 
mAb-iFt, boosted on day 21 and challenged on day 35 with 10,000 CFUs of iFt LVS. On 
day 2 post-infection the peritoneal exudate cells of immunized mice were harvested and 
the expression of F4/80, MHC class II, B7.1 (CD80), and B7.2 (CD86) were analyzed by 
flow cytometry. Results shown are mean ± SD from three independent experiments 
determined by one-way ANOVA and Student’s t-test (* P-value ˂ 0.1; ** P-value ˂ 0.05). 
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 These results demonstrate for the first time that intranasal immunization with 
mAb-iFt favors a pro-inflammatory cytokine profile secreted by murine macrophages as 
depicted by an increase of IL-12p70 and TNF-α production and inhibition of IL-10.  
Moreover, it triggers activation of peritoneal macrophages during F. tularensis infection, 
indicating the induction of a systemic response in vivo.  
 
F. tularensis LPS contributes to the anti-inflammatory properties of F. tularensis 
LVS in an IFN-γ and IL-10 dependent manner 
  It is well established that F. tularensis LPS is structurally different from other 
intracellular bacteria and elicits a subdued inflammatory response in the initial stages of 
infection, which otherwise are critical in controlling bacterial burden (Ancuta et al., 1996; 
Barker et al., 2006; Duenas et al., 2006; Hajjar et al., 2006).  To investigate the effect F. 
tularensis LPS on the cytokine profile produced by PECs, the levels of IL-12p70, TNF-α 
and IL-10 were measured in the supernatants of PECs from naïve C57BL/6 mice cultured 
with various concentrations of F. tularensis LPS.  As expected, incubation with F. 
tularensis LPS at different concentrations triggered significantly lower levels of IL-12p70 
(Fig. 3A) and TNF-α (Fig. 3B) secretion compared to E. coli LPS (positive control).  In 
contrast, IL-10 production was elevated in the presence of F.tularensis LPS (Fig. 3C).  
This observation not only confirms the low endotoxic activity of F. tularensis LPS but 
also indicates that it down-regulates Th-1 cell mediated inflammatory responses via up-
regulation of IL-10 and down-regulation of IL-12p70 and TNF-α.  
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Fig. 3 F. tularensis LPS contributes to the anti-inflammatory properties of F. 
tularensis LVS during the early stages of infection 
PECs from C57BL/6 mice (n=5 for each group) were obtained and cultured in a 96-well 
plate at 2 x 10
5
 cells/well in the presence or absence of either Ft-LPS or E. coli-LPS at 1 
ng/mL, 10 ng/mL and 20 ng/ml. Cells incubated with PBS were used as a control. Levels 
of IL-12p70, TNF-α and IL-10 were measured using BD Biosciences Cytometric Bead 
Array (CBA) following vendor instructions. Results shown are mean ± SD from three 
independent experiments determined by one-way ANOVA (* P-value ˂ 0.1; ** P-value ˂ 
0.05). 
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Several studies have shown that IL-10 negatively regulates synthesis of IFN-γ as 
well as synthesis of other pro-inflammatory cytokines in monocytes and macrophages 
(Donnelly et al., 1995; Brustoski et al., 2005; Cope et al., 2011).  Due to the increased 
levels of IL-10 synthesis after incubation of PECs with F. tularensis LPS it was of 
interest to examine whether this up-regulation correlates with the decrease in TNF-α and 
IL-12p70 secretion.  To investigate this, PECs from C57BL/6 wild-type and IL-10
 
genetically deficient mice were incubated with F. tularensis LPS or E. coli LPS.  As 
previously observed, in the absence of endogenous IFN-γ, F. tularensis LPS portrayed 
anti-inflammatory properties via up-regulation of IL-10 production and decrease in the 
synthesis of IL-12p70 and TNF-α by the PECs.  Interestingly, these results were reversed 
by the addition of exogenous IFN-γ (Fig. 4A-4C).  Lack of endogenous IL-10, in turn, 
resulted in an elevated synthesis of IL-12p70 (Fig.4D) and TNF-α (Fig. 4E).  These 
results indicate that increased levels of IL-10 synthesis is one of the mechanisms 
responsible for suppressing the protective pro-inflammatory cytokines such as TNF-α and 
IL-12p70 leading to an overall suppression of the Th-1 response and reduced IFN-γ 
levels in the early stages of F. tularensis infection.  In fact, the importance of IFN-γ 
during F. tularensis infection was reported by Rawool and colleagues (Rawool et al., 
2008), who observed a significant drop in survival rate in the mAb-iFt immunized IFN-γ-
/-
 mice compared to the wild type control.  
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Fig. 4 Anti-inflammatory effect of F. tularensis LPS on mouse PECs is IFN-γ and 
IL-10 dependent  
PECs from naïve and IL-10 genetically deficient C57BL/6 mice (n=5 for each group) 
were obtained and resuspended in cell culture media. PECs were cultured in a 96-well 
plate at 2 x 10
5
 cells/well with either Ft-LPS or E. coli-LPS at 1 ng/mL in the presence or 
absence of recombinant IFN-γ at 100 U/ml. Cells cultured with PBS were used as a 
control. The cytokine production was measured using BD Biosciences Cytometric Bead 
Array (CBA) following vendor instructions. Results shown are mean ± SD from three 
independent experiments determined by one-way ANOVA and Student’s t-test (* P-value 
˂ 0.1; ** P-value ˂ 0.05). 
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Administration of mAb-iFt immune complexes reverses the anti-inflammatory 
properties of F. tularensis LVS in the lungs of immunized mice 
  The balance and kinetics of pro- and anti-inflammatory cytokine secretion during 
F. tularensis challenge are key players in controlling the outcome of infection (Bosio et 
al., 2007; Mares et al., 2008; Sharma et al., 2009).  Consequently, having shown that 
immunization of mice with mAb-iFt favors a pro-inflammatory cytokine profile secreted 
by PECs in vitro, the attempt was to determine the effect of our FcγR targeting approach 
on the levels of inflammatory cytokines in the lungs of immunized mice during the early 
stages of F. tularensis LVS infection.  To accomplish this, C57BL/6 mice were 
immunized with PBS, or iFt, or mAb-iFt, boosted on day 21 and infected with a lethal 
dose of F. tularensis LVS on day 35 post-immunization.  The lungs of euthanized mice 
were harvested after 24, 48 and 96 hours post-challenge, homogenized, and the IL-6, IL-
10, TNF-α and IFN-γ cytokine levels were measured by direct sandwich ELISAs.  The 
obtained results indicate a faster pro-inflammatory response in the lungs of mAb-iFt 
immunized mice compared to mice immunized with iFt alone, as assessed by the IL-6 
and TNF-α production kinetics.  Levels of IL-6 and TNF-α peaked at 48 hours post-
infection, while they were significantly decreased by day 4 post-challenge (Fig. 5).  This 
observation was accompanied by a drop of the bacterial load (data not shown).  On the 
other hand, the pro-inflammatory cytokine levels tested continued to increase at 96 hours 
post infection in both the PBS and iFt immunized mice accompanied by an increase in 
the bacterial burden in the lungs (Fig. 5 and data not shown).  Similar results among the 
three groups of mice were noted with IFN-γ (Fig. 5).  On the contrary, the levels of IL-10 
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were significantly higher in mice immunized with either iFt or PBS versus mAb-iFt 
within the first 24 of infection, indicating the early anti-inflammatory properties of F. 
tularensis LVS.  Importantly, the decrease of IL-10 in the mAb-iFt immunized mice 
observed at 96 hours post-infection was consistent with the previous observation, 
indicating that FcγR targeting shifts towards a pro-inflammatory cytokine profile at the 
early stages of F. tularensis infection (Fig. 2 and Fig. 5).  
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Fig. 5: Administration of mAb-iFt immune complexes reverses the anti-
inflammatory properties of LVS in the lungs of immunized mice  
C57BL/6 mice (n=6 for each group) were immunized i.n. with PBS, iFt (2x10
7
 CFUs), or 
mAb-iFt, boosted on day 21 and challenged on day 35 with 10,000 CFUs of F.tularensis 
LVS. Lung tissue homogenates were obtained from immunized mice 24, 48 and 96 hours 
post-infection as indicated above and spun down at 15,000g for 30 minutes at room 
temperature to remove tissue debris. Cytokine levels were detected by using the IL-6, IL-
10, TNF-α and IFN-γ ELISA kits and following vendor instructions (Biolegend). Results 
shown are mean ± SD from three independent experiments determined by one-way 
ANOVA (* P-value ˂ 0.1; ** P-value ˂ 0.05).  
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FcγR targeting drives polarization of mouse macrophages towards the AM1 
phenotype at the early stages of F. tularensis LVS infection 
 The results of these experiments have suggested so far that one of the immune 
evasion mechanisms exploited by F. tularensis is the reduction of pro-inflammatory 
cytokines during the early stages of infection.  To further investigate possible 
mechanisms responsible for this shift in the innate immune response, the effect of FcγR 
targeting on macrophage activation and phenotype was analyzed in the lungs of 
immunized mice.  Previous research showed that one of the ways of F. tularensis survival 
and replication within the host cell is its ability to alter the macrophage activation from 
classically activated alveolar macrophages (AM1) to alternatively activated alveolar 
macrophages (AM2) (Shirey et al., 2008).  The AM1 macrophages are characterized by 
high levels of pro-inflammatory cytokines and thus, play an essential role in anti-bacterial 
innate immune response. In contrast, AM2 macrophages are associated with high levels 
of anti-inflammatory cytokines, in particular IL-10 (Katakura et al., 2004; Tomioka et al., 
2012).  Therefore, the flow cytometric analysis was performed to assess the number of 
AM1 and AM2 present upon immunization with mAb-iFt.  C57BL/6 mice were 
immunized with PBS, iFt, or mAb-iFt, boosted on day 21 and infected with a lethal dose 
of F. tularensis LVS on day 35 post-immunization.  The lungs of euthanized mice were 
harvested 24, 48 and 96 hours post-challenge and the levels of F4/80, CD11b, CCR7, 
MHC class II and B7.2 marker expression on white blood cells was analyzed by flow 
cytometry. Classically activated AM1 cells are characterized as 
F4/80
+
/CD11b
int
/CCR7
+
/MHC classII
+
/B7.2
+
 cells, while AM2 cells were identified as 
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F4/80
+
/CD11b
int
/CCR7
-
/ MHC classII
-
/B7.2
-
 (Mantovani et al., 2004; Tomioka et al., 
2012).  The frequency and number of AM1 cells was significantly higher in mAb-iFt 
immunized group of mice compared to mice immunized with iFt alone, especially at the 
early stages of F. tularensis LVS infection 24 and 48 hours post challenge (Fig. 6).  
Interestingly, the levels of AM1 cells were comparable among the different immunized 
groups at 96 hours of post challenge. In addition, the data showed a significantly lower 
number of AM2 cells in the lungs of mAb-iFt immunized mice relative to mice 
immunized with iFt alone at all three time points post-infection.  It is also of interest that 
mice immunized with PBS had the highest frequency of AM2 cells, proposing that AM2 
polarization in vivo may be an additional immune evasion strategy of F. tularensis, 
especially at the early stages of infection.  
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Fig. 6 FcγR targeting drives polarization of mouse macrophages towards the AM1 
phenotype at the early stages of LVS infection  
Lungs of immunized mice (n=6 for each group) were harvested 24, 48 and 96 hours post-
infection. For cell surface marker staining, cells were washed with PBS-BSA-azide, 
resuspended in blocking buffer [PBS-BSA-azide plus 30 µg/ml of normal mouse IgG 
(Sigma)] and incubated on ice for 30 minutes. Cells were then washed with PBS-BSA-
azide and fluorescently labeled antibodies to CD11b, F4/80, MHC class II, B7.1, B7.2, 
CCR7, or their corresponding isotype controls were added. The cells were then incubated 
on ice for 30 minutes, washed, and then fixed with 2% paraformaldehyde. Cells were 
then analyzed by flow cytometry on an LSRII flow cytometer (BD Biosciences). Results 
shown are mean ± SD from three independent experiments determined by one-way 
ANOVA (* P-value ˂ 0.1; ** P-value ˂ 0.05). 
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Enhanced maturation and activation of DCs in the lungs of mice immunized 
intranasally with mAb-iFt ICs 
It has been previously demonstrated that targeting iFt to FcγRs via the intranasal 
administration of pre-formed mAb-iFt ICs elicits protective responses against lethal 
challenges with F. tularensis LVS, and the category A F. tularensis agent, SchuS4 
(Rawool et al., 2008; Czerkinsky et al., 2012).  The protection observed was based on 
survival studies, bacterial burdens, and immunohistochemical analysis of mouse tissues.  
The protective effect was due to targeting of bacterial antigens to FcγR through 
opsonization with an anti-LPS IgG2a mAb.  The antibody alone had no protective effect 
on mice against F. tularensis challenge.  Furthermore, it was shown that targeting iFt to 
FcRs on APCs mediates internalization, processing, and presentation of the immunogen 
to F. tularensis-specific T-cell hybridoma in vitro (Rawool et al., 2008, Iglesias et al., 
2012).  Since DCs play a key role in processing and presenting antigens to T 
lymphocytes, effectively bridging the innate and adaptive immune system, experiments 
were designed to focus on the effect immunization with mAb-iFt ICs has on the number 
of activated DCs in the lungs of immunized mice.  For this purpose, C57BL/6 mice were 
immunized with PBS, iFt, F(ab’)2-iFt or mAb-iFt and boosted on day 21.  On day 35 
post-immunization, lungs were harvested, digested, and the DCs were purified using 
lympholyte, followed by a one hour incubation at 37
o
C on petri dishes to negatively 
select for the adherent cells, such as macrophages.  Following selection, we used the 
expression of CD11c and DEC-205 markers to define lung DCs ( Witmer-Pack et al., 
1995; Kronin et al., 2000; Bonifaz et al., 2004).  All the selected cells that were CD11c
+
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were also positive for the dectin marker (DEC-205), indicating the DC purity of more 
than 98% (data not shown).  The activation status of lung DCs was based upon the 
expression of MHC class II, B7.1, and B7.2 and the analysis was performed by flow 
cytometry.  Interestingly, no significant differences were noted among the three groups of 
immunized mice (data not shown).  In contrast, when immunized mice were infected with 
a lethal dose of F. tularensis LVS on day 35 post-immunization, and their DC profile was 
analyzed at different time points post-infection, there was a significant difference in the 
frequency and activation status of lung DCs between the iFt and mAb-iFt groups.  More 
specifically, on days 2 and 5 post-infection there was a significantly higher number of 
CD11c
+
/DEC-205
+
 cells in the lungs of mAb-iFt immunized mice compared to mice 
immunized with iFt alone or F(ab’)2-iFt (Fig. 7B and 7C), potentially indicating 
increased recruitment of DCs in the lungs during infection.  This difference was not 
significant on day 7 (Fig. 7D).  It is also interesting to note that the overall white blood 
cell (WBC) cellularity in the lungs of mAb-iFt immunized mice was significantly 
increased following F. tularensis LVS challenge (Fig. 7A).  
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Fig. 7 Immunization of mice with mAb-iFt immune complexes enhances the number 
of CD11c
+
 cells in the lungs of immunized mice following F. tularensis LVS challenge 
 C57BL/6 mice (n=6 for each group) were immunized i.n. with PBS, iFt (1x10
9
 CFUs), 
F(ab’)2-iFt or mAb-iFt, boosted on day 21 and challenged on day 35 with 20,000 CFUs 
of F.tularensis LVS. On days 2, 5, and 7 post-infection the lungs of immunized mice were 
harvested and the white blood cells were obtained and counted (A). Lungs were also 
harvested from unimmunized and uninfected mice (naïve) as a baseline control. The 
frequency of CD11c
+
/DEC-205
+
 cells was measured by flow cytometry and translated 
into absolute numbers for days 2 (B), 5 (C), and 7 (D) post-infection. Naïve mice were 
neither immunized nor challenged. Results shown are mean ± SD from three independent 
experiments determined by one-way ANOVA and Student’s t-test (* P-value ˂ 0.1; ** P-
value ˂ 0.05). There was no significant difference between the two groups on day 7 post 
LVS infection.  
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On a similar note, the expression (Fig. 8) and absolute numbers (Fig. 9) of 
CD11c
+
 cells expressing MHC class II, B7.1, and B7.2 were significantly higher in the 
mAb-iFt immunized group compared to the group immunized with iFt alone or F(ab’)2-
iFt, indicating for the first time that mucosal targeting of an immunogen to FcR does not 
only enhance the frequency of DCs in the lungs upon subsequent infection, but also 
mediates in vivo DC maturation and activation enabling them to become better antigen 
presenting cells.  
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Fig. 8 Increased frequency of activated CD11c+ dendritic cells in the lungs of mice 
immunized with mAb-iFt immune complexes and challenged with F. tularensis LVS 
C57BL/6 mice (n=3 for each group) were immunized i.n. with PBS, iFt (1x10
9
 CFUs), 
F(ab’)2-iFt or mAb-iFt, boosted on day 21, and challenged on day 35 with 20,000 CFUs 
of iFt LVS. On day 2 post- LVS infection the lungs of immunized mice were harvested 
and the white blood cells were stained and analyzed by flow cytometry to obtain the 
expression levels of MHC class II (A), B7.1 (B), and B7.2 (C) on lung dendritic cells 
(CD11c
+
/DEC-205
+
). Results shown are representative of three independent experiments.  
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Fig. 9 Immunization of mice with mAb- iFt immune complexes increases the 
number of activated CD11c
+
 lung dendritic cells following F. tularensis LVS 
challenge  
C57BL/6 mice (n=6 for each group) were immunized and challenged as in Fig. 8. On 
days 2 and 5 post- F. tularensis LVS infection the lungs of immunized mice were 
harvested and the white blood cells were obtained and counted. The frequencies of 
CD11c
+
/DEC-205
+
/MHC class II
+
 (A), CD11c
+
/DEC-205
+
/B7.1
+
 (B), and CD11c
+
/DEC-
205
+
/B7.2
+
 (C) were translated into absolute cell numbers. Results shown are mean ± SD 
from three independent experiments determined by one-way ANOVA (* P-value ˂ 0.1; 
** P-value ˂ 0.05). 
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Immunization with mAb-iFt ICs enhances the generation of effector memory CD4
+
 
T cells during F. tularensis LVS challenge 
 Memory T cell responses are often required to resolve intracellular bacterial 
infections, hence effective vaccines should have the ability to generate long-lasting, 
memory T cell populations.  Memory cells are divided into central memory (CM) and 
effector memory (EM) cells based on their expression of cell surface receptors.  More 
specifically, although both types of memory cells are positive for the adhesion molecule 
CD44, CM T cells are also positive for CD62L and the chemokine receptor CCR7, while 
EM T cells lack both (Sallusto et al., 1999; Kaech et al., 2002; Esser; et al., 2003). 
It has been previously shown that targeting iFt to FcR via intranasal 
immunization with ICs generates protection against lethal F. tularensis challenge in an 
IFN- dependent fashion, indicative of a T cell recall response (Rawool et al., 2008).  
Having established that intranasal immunization with mAb-iFt ICs increases the number 
of activated DCs in the lungs during F. tularensis LVS infection, and antigen 
presentation by DCs can effectively program T lymphocytes to differentiate into memory 
cells (Esser et al., 2003), an experiment was designed to determine the effect FcR 
targeting on the generation of memory CD4
+
 T cells.  For this purpose, C57BL/6 mice 
were immunized with PBS, or iFt, F(ab’)2-iFt or mAb-iFt and boosted on day 21.  On 
day 35 post-immunization, the lungs and spleens of immunized mice were harvested and 
the lymphocytes were stained with the relevant mAb followed by flow cytometric 
analysis as described in the Materials and Methods.  In accordance with previous studies, 
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EM CD4
+
 T cells were characterized as CD3
+
/CD4
+
/CD44
high
/CD62L
low
/CCR7
-
, while 
the phenotype of CM memory CD4
+
 T cells was 
CD3
+
/CD4
+
/CD44
high
/CD62L
high
/CCR7
+
. Interestingly, regardless of the type of 
immunization, there was no generation of EM CD4
+
 T cells in the spleen or lungs of 
immunized mice (Fig. 10A). In fact, a similar population of CM T cells was present in all 
three groups, regardless of the type of immunogen used (Fig. 10A). Most importantly 
though, F. tularensis LVS infection of immunized mice generated a population of EM 
CD4
+ 
T cells both in the lungs and spleens of mice within two days post infection (Fig. 
10B ). The levels of EM CD4
+
 T cells elicited during bacterial challenge were 
significantly higher in the mAb-iFt immunized group compared to iFt (Fig. 10B).  The 
cells characterized as CM CD4
+
 T cells were also CCR7
+
 while the EM CD4 cells had 
very low levels of CCR7 expression (data not shown).  The enhancement of the effector 
T cell population in the mAb-iFt IC immunized group indicated that targeting antigens to 
FcR can drive the generation of effector memory immune responses both locally (lung) 
and systemically (spleen) during bacterial infection.  Mice immunized with F(ab’)2-iFt 
ICs followed by F. tularensis  LVS challenge, generated similar levels of EM CD4
+
 T 
cells compared to the iFt immunized group, confirming that Fc receptor targeting of the 
immunogen is essential for this observation (Fig. 10B-10C).  Importantly, the EM CD4
+
 
T cells generated following Fc receptor targeting of iFt were persistent for at least 25 
days after F. tularensis LVS infection (Fig. 10B). 
Interestingly, the population of central memory CD4
+
 T cells was negligible 
within two days following F. tularensis LVS infection in all three groups of mice (Fig. 
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10B).  The qualitative (Fig.10B) and quantitative (Fig.10C) enhanced generation of 
effector versus central memory T cells observed in the mAb-iFt immunized group, 
suggests that EM CD4
+
 T cells have a more pivotal role in mediating protection against 
lethal F. tularensis LVS challenge over their CM counterparts.  
  Currently, the generation of effector vs central memory CD8
+
 T lymphocytes in 
F. tularensis model is being evaluated as this subpopulation of T cells have also been 
shown to play an important role in protection against this mucosal bacterial pathogen 
(Conlan et al., 1994; Yee et al., 1996). 
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Fig. 10 Enhanced generation of effector memory CD4
+
 T cells in the spleen and 
lungs of mice immunized with mAb- iFt ICs, following F. tularensis LVS challenge 
C57BL/6 mice (n=3 for each group) were immunized with PBS, iFt, mAb- iFt or F(ab’)2-
iFt and challenged as described in Fig. 7. On day 35 post-immunization or on day 2 post-
F. tularensis LVS challenge, the lungs and spleens of immunized mice were harvested 
and the white blood cells were obtained and counted. Expression levels of 
CD3
+
/CD4
+
/CD44
+
/CD62L
+
/CCR7
+
 T cells post-immunization (A) and post-infection 
(B), as well as their absolute numbers (C) were analyzed by flow cytometry. The effector 
memory cells (EM) are presented as CD44
+
 / CD62L
-
 while the central memory cells 
(CM) are presented as CD44
+
 / CD62L
+
. Results shown are mean ± SD from three 
independent experiments determined by one-way ANOVA and Student’s t-test (* P-value 
˂ 0.1; ** P-value ˂ 0.05). 
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IL-12 is necessary for protection against lethal F. tularensis LVS challenge following 
immunization with mAb-iFt ICs 
The importance of T cells and IFN- in protection against F. tularensis LVS 
infection following immunization with mAb-iFt ICs provides evidence for the generation 
of a Th-1- like protective immune response. It is widely established that IL-12, secreted 
mainly by innate immune cells, such as DCs and macrophages, drives the differentiation 
of Th-1 effector T cells (Hsieh et al., 1993).  Thus, it was hypothesized that the protective 
immune responses elicited following targeting of iFt to FcR are dependent upon IL-12. 
In order to confirm this hypothesis, IL-12p35-deficient mice, and their control 
counterparts (C57BL/6), were immunized with PBS, iFt, or mAb-iFt, boosted on day 21, 
and infected with a lethal dose of F. tularensis LVS on day 35 post-immunization.  The 
mice deficient for the p35 IL-12 subunit (as opposed to p40 deficient mice) have been 
selected due to the role of the p35 gene in the development of Th-1 responses (Liu et al., 
2003). In addition, the p40 subunit is not unique to IL-12 as it is also shared by IL-23.  
As anticipated, based on previous studies, 100% of the C57BL/6 mice that were 
immunized with mAb-iFt ICs survived the F. tularensis LVS challenge while 
immunization with iFt alone provided only 50% protection (Fig. 11A).  IL-12p35-
deficient mice though succumbed to infection within 13 days, regardless of the type of 
immunization indicating the importance of IL-12 in protection generated by FcγR 
targeting (Fig.11B).  The role of IL-12 in protection against lethal F. tularensis challenge 
is evident in both the iFt and mAb-iFt immunized IL-12p35-deficient mice as both 
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groups completely succumbed to the infection.  This indicates that targeting of the fixed 
bacterial immunogen to FcγR on APCs drives the production of higher levels of IL-12 
during F. tularensis LVS challenge compared to iFt alone pointing towards quantitative 
versus qualitative difference between the two immunization approaches.  In addition, 
there was significantly more lung DCs producing IL-12 from mAb-iFt IC immunized 
mice following F. tularensis LVS challenge, than from challenged mice immunized with 
iFt alone.  The numbers of lung DCs positive for IL-12 from challenged mice immunized 
with the F(ab’)2-iFt ICs were also comparable to the iFt group, indicating that the 
increase in IL-12 production from lung DCs is FcγR-targeting dependent (Fig. 11C).  
Furthermore, culture of peritoneal cells (PECs) from mAb-iFt immunized and challenged 
mice with live F. tularensis LVS, led to significantly higher levels of IL-12p70 secretion 
as compared to PECs from challenged mice immunized with iFt alone (Fig. 11D).  These 
data, collectively, present for the first time the importance of IL-12 in generating 
protective responses against F. tularensis LVS challenge when utilizing our FcγR 
targeting vaccine model. 
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Fig. 11 Targeting of iFt to FcγR provides protection against F. tularensis LVS 
challenge in an IL-12-dependant fashion 
 C57BL/6 (A) or IL-12-deficient mice (B) (n=6 for each group) were immunized i.n. with 
PBS, iFt (1x10
9
 CFUs), or mAb- iFt, boosted on day 21 and challenged on day 35 with 
20,000 CFUs of F. tularensis LVS. Survival was monitored for 25 days post-infection 
and survival curves were generated using the Log-Rank (Mantel-Cox) test. The P- value 
for iFt versus mAb- iFt in A (C57BL/6) was 0.041. There was no significant difference 
between iFt and mAb- iFt immunized IL-12-deficient mice (B). C57BL/6 (C and D) mice 
were immunized i.n. with PBS, iFt (1x10
9
 CFUs), mAb- iFt, or F(ab’)2- iFt, boosted on 
day 21 and challenged on day 35 with 20,000 CFUs of F. tularensis LVS. Two days post-
infection lung DCs were obtained as previously described and stained intracellularly for 
IL-12 (C). Peritoneal exudate cells (PECs) were also obtained from all groups and 
cultured for 24 hours or 48 hours with F. tularensis LVS (1 x 10
3
 CFUs /well). 
Supernatants were collected at designated time points and the levels of IL-12p70 were 
measured by CBA (D). Statistical analyses were carried out using the one-way ANOVA 
(* P-value ˂ 0.1; ** P-value ˂ 0.05). 
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IL-12 is required for the generation of effector memory CD4
+
 T cells upon 
intranasal immunization with mAb-iFt IC and subsequent F. tularensis LVS 
challenge 
Having established that protection against F. tularensis LVS challenge via 
intranasal immunization with mAb-iFt ICs is IL-12 dependent, the role of the latter in the 
generation of effector memory CD4
+
 T cells following FcR targeting was also 
examined. C57BL/6 mice were immunized i.n. with PBS, iFt, or mAb-iFt, boosted on 
day 21, and challenged on day 35 with a lethal dose of F. tularensis LVS.  Mice were 
also injected i.p. with rat IgG2a anti-IL-12p35 or the isotype control on days 0, and 1 
post-F. tularensis LVS infection.  On day 2 after F. tularensis LVS challenge the levels 
of effector memory CD4
+
 T cells in the lungs and spleens of immunized mice were 
analyzed by flow cytometry.  The data indicated that neutralization of IL-12 in vivo via 
the administration of anti-IL-12 mAb significantly reduced the frequency and number of 
effector memory CD4
+
 T cells both in the lungs and spleen of immunized mice (Fig. 12A 
and 13A, respectively). In accordance with these results, immunization of IL-12-deficient 
mice with iFt or mAb-iFt ICs, followed by lethal LVS infection, failed to enhance the 
generation of effector memory CD4
+
 T cells in both the lungs and the spleens of 
immunized mice (Fig. 12B and 13B).  Altogether, these data suggest that the necessity of 
IL-12 for protection against lethal F. tularensis LVS challenge is, in part, due to the 
ability of IL-12 to generate EM CD4
+ 
T cells, following targeting of bacterial 
immunogens to FcγR. 
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Fig. 12 Generation of effector memory CD4
+
 T cells following targeting of iFt to 
FcγR, during F. tularensis LVS challenge, is IL-12-dependant 
C57BL/6 (A) or IL-12-deficient mice (B) (n=4 for each group) were immunized and 
challenged as described in Fig. 11. C57BL/6 mice were also injected i.p. with rat IgG2a 
anti-IL-12 (500mg/dose), or the control isotype, on days -1, 0, and 1 post-LVS infection. 
On day 2 after F. tularensis LVS challenge, the lungs and spleens of immunized C57BL/6 
mice (A) and IL-12-deficient mice (B) were harvested and the white blood cells were 
obtained and counted. Expression levels of CD3
+
/CD4
+
/CD44
+
/CD62L
+
/CCR7
+ 
T cells in 
the lungs and spleens of immunized C57BL/6 mice (A) and IL-12-deficient mice (B) 
were obtained by flow cytometry. The effector memory cells are presented as CD44
+
 / 
CD62L
- 
while the central memory cells are presented as CD44
+
 / CD62L
+
. Results are 
representative of three independent experiments.  
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Fig. 13 Immunization of mice with mAb- iFt immune complexes increases the 
absolute numbers of effector memory CD4
+
 T cells, during F.tularensis LVS 
infection, in an IL-12-dependant fashion 
 Immunization and challenge studies were conducted in C57BL/6 (A) or IL-12-deficient 
mice (B) (n=4 for each group) as in Fig. 11. On day 2 after F. tularensis LVS challenge, 
the lungs and spleens of immunized mice were harvested and the lymphocytes were 
obtained and counted. C57BL/6 mice were also injected i.p. with rat IgG2a anti-IL-12 
(500mg/dose), or the control isotype, on days -1, 0, and 1 after LVS infection. Expression 
levels of CD3
+
/CD4
+
/CD44
+
/CD62L
+
/CCR7
+
 T cells in the lungs and spleens of 
immunized C57BL/6 mice (A) and IL-12-deficient mice (B) were obtained by flow 
cytometry and their absolute numbers were calculated. Results shown are mean ± SD 
from three independent experiments. Statistical analyses were carried out using the one-
way ANOVA (* P-value ˂ 0.1; ** P-value ˂ 0.05). 
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Enhanced generation of IFN- secreting CD4+ effector memory T cells during F. 
tularensis LVS challenge in mice immunized i.n. with mAb-iFt ICs 
The importance of IFN- in protection against F. tularensis LVS challenge, and 
the enhanced generation of effector CD4
+
 memory T cells following mAb-iFt 
immunization, led to hypothesis that the latter cell population is involved in the 
production of IFN- during F. tularensis LVS infection.  To test this, C57BL/6 mice were 
immunized i.n. with PBS, iFt, or mAb-iFt, boosted on day 21, and challenged on day 35 
with a lethal dose of F. tularensis LVS.  Two days post-challenge, splenocytes from 
immunized mice were obtained and cultured for 5 hours in the presence or absence of F. 
tularensis LVS, while PMA and ionomycin were used as positive controls.  Following 
incubation, cells were collected and pooled from each group, stained for the extracellular 
markers CD4/CD44/CD62L/CCR7 and intracellularly for IFN-.  As depicted in Figure 
14, there were significantly more F.tularensis-specific CD4
+
 splenocytes from mAb-iFt 
immunized mice that secreted IFN- upon in vitro re-stimulation.  The CD4+ / IFN-+ 
double positive cells also possessed the EM phenotype (CD44
+
/CD62L
low
/CCR7
-
).  
These observations indicate that the source of IFN-, essential for protection against F. 
tularensis LVS challenge, is at least in part the effector memory CD4
+
 T cells generated 
following i.n. immunization with mAb-iFt ICs.  Surprisingly, the CD4
-
/IFN-γ+ population 
observed were not CD8
+
 T lymphocytes (data not shown).  
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Fig. 14 Increased generation of IFN-γ producing effector CD4+ T cells in mice 
immunized with mAb- iFt IC compared to mice immunized with iFt alone 
C57BL/6 (n=4 for each group) were immunized and challenged as described in Fig. 7. On 
day 2 after F. tularensis LVS challenge, the spleens were harvested and splenocytes were 
cultured for 5 hours with F. tularensis LVS (1 x 10
3 
CFUs per 2 x 10
5
 SPCs/well). 
Following incubation cells from each group were pooled, counted, and stained 
extracellularly for CD4, CD44, CD62L and CCR7 and intracellularly for IFN-γ. Analysis 
(A) and enumeration (B) of IFN-γ+ effector CD4+ T cells were done by flow cytometry. 
Data shown are mean ± SD from two independent experiments determined by Student’s t-
test. The P- value for the iFt versus the mAb- iFt group in panel B was 0.03 (* P-value ˂ 
0.1; ** P-value ˂ 0.05). 
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Discussion 
 
 
 
Francisella tularensis is a Gram-negative intracellular bacterium that causes 
tularemia, a disease that could potentially be fatal in humans and animals.  It can be 
transmitted through insect bites, infected carcasses, contaminated water, and inhalation of 
contaminated air (Metzger et al., 2007).  Because of its high infectivity the Centers for 
Disease Control and Prevention designates F. tularensis as a Category A biological agent 
(Rotz et al., 2002).  The search for a safe and effective vaccine against infectious 
tularemia is still ongoing due to the lack of clear understanding of its pathogenesis.  One 
of the major questions is to understand pathobiology of the bacterium and to evaluate the 
host’s immune responses in the early stages of infection.  
The current study demonstrated for the first time that targeting of inactivated F. 
tularensis (iFt) bacteria to Fcγ receptors via formation of immune complexes reverses the 
potential detrimental effect of IL-10 during the early stages of F. tularensis infection.  
Due to the lack of an identified F. tularensis protective antigen, the focus was on an 
inactivated vaccine, which has been shown to protect against highly virulent SchuS4 
organism in the highly stringent animal model C57BL/6 (Rawool et al., 2008).  
Early control of bacterial infection depends on the secretion of pro-inflammatory 
cytokines that regulate the activation of antigen presenting cells and the generation of a 
protective Th-1-like response (Medzhitov & Janeway, 1997; Pashine et al., 2005; 
Kalinski, 2012).  One of the characteristics of F. tularensis infection is the lack of such 
responses during early progression of infection.  While some studies depict that this 
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effect is due to the low endotoxicity of F. tularensis lipopolysaccharide, which is 
structurally different from other Gram-negative bacteria (Ancuta et al., 1996; Barker et 
al., 2006; Duenas et al., 2006; Hajjar et al., 2006), other studies show that the potential 
up-regulation of anti-inflammatory cytokines is an important factor in the progression of 
F. tularensis infection (Woolard et al., 2007; Metzger et al., 2013).  The latter could 
possibly be due to suppression of the early activation of inflammasome by F. tularensis, 
one of the mechanisms that the bacteria utilizes to evade the early immune response 
(Huang et al., 2010; Ulland et al., 2010; Dotson et al., 2013).   
The anti-inflammatory cytokine IL-10 plays a major role in suppression of host 
immune system by inhibiting the antigen presentation ability of macrophages and 
dendritic cells mainly by down-regulating the expression of CD80, CD86 and MHC class 
II molecules, as well as the production of pro-inflammatory cytokines (Pestka et al., 
2004).  The ability of IL-10 to suppress innate, inflammatory responses against 
intracellular pathogens has been previously reported. For instance, lack of endogenous 
IL-10 production led to a decrease in number of Trypanosoma cruzi parasites in the blood 
of infected mice (Abrahamsohn & Coffman, 1996).  Similarly, lack of IL-10 resulted in 
higher resistance of mice to Listeria monocytogenes (Dai et al., 1997).  In addition, 
viruses have also evolved mechanisms to escape the immune response by altering the 
Th1/Th2 balance.  Thus, it has been shown that elevated levels of IL-10 correlated with 
higher viral load in HIV infected individuals (Brockman et al., 2009).  
IL-10 has also been identified as a key regulator of immune response to F. 
tularensis infection (Metzger et al., 2013).  In particular, IL-10 mediates suppression of 
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IL-17, a cytokine that is essential in the initiation of a protective immune response to F. 
tularensis infection (Leiby et al., 1992; Elkins et al., 2003; Duckett et al., 2005; Lin et al., 
2009).   
It is well established that targeting of antigen to FcγRs using a receptor subclass-
specific monoclonal antibodies increases the binding, internalization and processing of an 
antigen by antigen presenting cells (APCs) in the absence of an adjuvant (Gosselin et al., 
1992).  Furthermore, targeting of inactivated F. tularensis bacteria to FcγRs through 
intranasal immunization of mice with mAb-iFt enhances immune response and protection 
against F. tularensis infection possibly via FcγR dependent enhanced uptake of the 
antigen by APCs and further presentation to T cells leading to enhanced T cell activation 
(Rawool et al., 2008; Iglesias et al., 2012).  The current study have showed that a 
potential mechanism of protection in the F. tularensis model utilized, following FcγR 
targeting of fixed bacteria, entails the generation of a Th-1 response during the early 
phases of F. tularensis infection, by inhibiting the synthesis of the anti-inflammatory 
cytokine IL-10.  
Numerous studies have demonstrated that during F. tularensis infection the early 
pro-inflammatory responses are significantly suppressed Bosio et al., 2007; Walters et al., 
2013), followed by overwhelming up-regulation after 48 hours of infection leading to a 
severe sepsis (Mares et al., 2008; Sharma et al., 2009).  The results of these current 
experiments show that iFt targeting to FcγRs up-regulates pro-inflammatory responses at 
early stages of F. tularensis infection both ex vivo and in vivo.  Particularly, immunization 
of C57BL/6 mice with mAb-iFt shifted the cytokine profile towards a pro-inflammatory 
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Th-1 type in the lungs and peritoneum of immunized mice during LVS infection, which 
was associated with reduction in bacterial load.  Conversely, immunization with PBS and 
the inactivated immunogen alone resulted in considerably lower amounts of Th1 
cytokines and higher amounts of IL-10 synthesis accompanied by an increase in bacterial 
burden in the lungs of infected mice.  These observations indicate that immunization of 
animals with mAb-iFt elicits a robust, pro-inflammatory immune response in the early 
phases of F. tularensis infection by reversing the inhibitory effect of IL-10 both locally 
and systemically.  
The components of F. tularensis that contribute to the inhibition of pro-
inflammatory responses are not completely understood yet.  However, it is well 
established that F.tularensis LPS shows low endotoxic activity due to its structural 
differences from other intracellular pathogens (Ancuta et al., 1996; Barker et al., 2006; 
Duenas et al., 2006; Hajjar et al., 2006).  These findings that F. tularensis LPS elicits 
inefficient pro-inflammatory response and up-regulates IL-10 synthesis indicate that LPS 
is partly responsible for the anti-inflammatory activities of F. tularensis LVS.  The 
importance of pro-inflammatory cytokines, in particular IFN-γ, in controlling the 
intracellular infection has been described in previous reports. IFN-γ deficiency in mice 
during Listeria monocytogenes infection compromised activation of macrophages 
allowing bacteria to escape from phagolysome and further replicate within cytoplasm 
(Dai et al., 1997).  Similarly, lack of IFN-γ resulted in decreased survival of mice and 
increase in bacterial burden during Legionella pneumophila infection (Shinozawa et al., 
2002).  In addition, IFN-γ dependent activation of human monocyte-derived macrophages 
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inhibited escape of F. tularensis into the cytoplasm, thus preventing bacterial replication 
(Santic et al., 2005).  In the current study it was observed that the increased IL-10 
synthesis in the early stages of F. tularensis infection coincided with a decrease of the 
pro-inflammatory cytokines IL-12p70 and TNF-α in the absence of endogenous IFN-γ.  
Addition of exogenous IFN-γ to cultures of LPS-treated PECs, however, was able to 
reverse this suppression.  Likewise, an increase in the synthesis of IL-12p70 and TNF-α 
was observed in IL-10 deficient mice after stimulation with F. tularensis LPS.  Therefore, 
these data demonstrate that early up-regulation of IL-10 is one of the means of Th-1 
immune response suppression during early stages of F. tularensis infection, enabling the 
bacteria to avoid classical anti-bacterial mechanisms.  
 The source of pro-inflammatory cytokines during infection is primarily the 
professional antigen presenting cells, such as dendritic cells and macrophages.  Proper 
activation and differentiation of macrophages and dendritic cells is important for the 
generation of robust, innate immune response against bacterial pathogens.  Depending on 
the extracellular cytokine background, the activated macrophages are divided into two 
distinct groups, classically activated macrophages (AM1) associated with high levels of 
pro-inflammatory cytokines and alternatively activated macrophages (AM2) 
characterized by increased levels of anti-inflammatory cytokines, in particular IL-10 
(Benoit et al., 2008).  In fact, IL-10 and CCL17, both produced by AM2, are key players 
in suppressing induction of AM1 cells (Katakura et al., 2004).  Shirey et al. (2008) 
demonstrated that F. tularensis LVS skews macrophage activation from anti-bacterial 
AM1 phenotype towards AM2, which allows its survival and uncontrolled replication 
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within host cells (Shirey et al., 2008).  Based on these findings, the hypothesis was that 
targeting of mAb-iFt may alter the macrophage phenotype from anti-inflammatory AM2 
to pro-inflammatory AM1.  The data showed that immunization of mice with mAb-iFt 
resulted in higher frequency and number of AM1 cells compared to mice immunized with 
iFt alone.  In addition, a significantly lower number of AM2 cells in the lungs of mAb-iFt 
immunized mice were observed relative to mice immunized with iFt alone.  Interestingly, 
immunization with PBS resulted in the highest frequency of AM2 cells, suggesting that 
AM2 polarization in vivo may be an additional immune evasion strategy of F. tularensis, 
especially at the early stages of infection.  
Further, it was demonstrated that this vaccination strategy increases the frequency 
and activation of DCs in the lungs of immunized mice during F. tularensis infection, 
while it enhances the generation of effector memory CD4
+
 T cells, both locally (lung) 
and systemically (spleen), in an IL-12-dependent fashion.  This effector memory cell 
population is believed to play an important role in the protection observed against F. 
tularensis LVS challenge, partly via its increased ability to produce IFN-.  Although the 
antibodies tend to form bacterial aggregates, the findings of this study depend upon 
specifically targeting antigens to FcγRs. In particular, it was observed that the 
immunization with F(ab’2) mAb-iFt ICs failed to enhance recruitment and activation of 
DCs in the lungs of immunized mice as well as to generate effector memory CD4
+
 T cells 
during infection.  These results are in agreement with previous reports where subdued 
immune responses were observed when utilizing immune complexes lacking Fc domain 
(Rawool et al., 2008; Iglesias et al., 2012).  
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Modulating DCs, one of the most important professional APCs of the immune 
system, presents an attractive target for vaccine design.  Indeed, DCs migrating from the 
periphery to secondary and tertiary lymphoid organs, loaded with exogenous antigens and 
activated by “danger signals”, identify naïve T cells and induce their proliferation and 
differentiation to effector and memory phenotypes.  Indeed, the superior capacity of DCs 
to activate naïve T cells following nasal and oral immunizations has been determined in 
several studies (Vermaelen et al., 2001; Anjuere et al., 2004; Chirdo et al., 2005; 
Wikstrom et al., 2006; Jaensson et al., 2008).  In the current study, targeting iFt to FcR 
via intranasal immunization of mice with mAb-iFt ICs increased the overall white blood 
cell cellularity of immunized mice during F. tularensis LVS infection compared to mice 
immunized with iFt alone.  Most importantly, the frequency and activation status of lung 
DCs was also significantly increased post-challenge. Mice immunized with F(ab’)2 – iFt 
ICs failed to recruit and increase the activation of DCs in the lungs, indicating that this 
effect is dependent upon targeting of the immunogen to FcγRs.  However, it is currently 
unclear whether expression of FcγR is required for DCs recruitment and activation.  
Nevertheless, the enhanced generation of activated DCs in the lungs of mice immunized 
with ICs provides evidence of enhanced mucosal immunity. 
Although it has been previously established that FcγR targeting of a fixed 
bacterial immunogen (iFt) in vitro leads to DC activation (Iglesias et al., 2012), the exact 
mechanism that leads to their in vivo maturation and potential recruitment in the lungs 
remains unclear.  At different developmental stages and at various anatomical sites DCs 
may express various chemokine receptors including: CCR1, CCR2, CCR4, CCR5, 
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CCR6, CCR7, CXCR1, and CXCR4 (Dieu et al., 1998; Cyster, 1999; Sallusto et al., 
1999(a); Sallusto et al., 1999(b); Sallusto et., 1999(c)).  These findings suggest that 
chemokines and chemokine receptor expression levels may regulate DC trafficking.  
Indeed, in various infection models, including Mycobacterium bovis, Schistosoma 
mansoni, and Cryptococcus neoformans, expression of CCR2 in mice was necessary for 
DC recruitment and activation (Chiu et al., 2004; Osterholzer et al., 2008).  Similarly, in 
two F. tularensis studies using F. tularensis LVS, CCR7
+
 DCs were found to be recruited 
in areas of high CCL19 and CCL21 chemokine concentrations (Bar-Haim et al., 2008; 
Chiavolini et al., 2010). Whether the levels of these chemokines are increased 
significantly in the lungs of IC immunized mice over mice administered with iFt alone, 
essentially recruiting mature DCs from peripheral sites remains to be addressed.  
Chemokine expression also plays a role in the recruitment of CD4
+ 
T cells at the 
sites of infection where they are exposed to concentrated amounts of polarizing 
cytokines, such as IL-12, secreted by the activated DCs (Osterholzer et al., 2008).  In the 
current study, lung DCs from mAb-iFt IC immunized mice had an increased ability to 
secrete IL-12 upon re-stimulation in vitro compared to mice immunized with the 
untargeted iFt.  The activated DCs would efficiently present F. tularensis antigens to 
CD4
+
 T cells polarizing them towards a Th-1 phenotype via secretion of IL-12 and 
driving their differentiation towards a protective effector memory phenotype.  
Furthermore, the observation that PECs showed increased secretion of IL-12 upon re-
stimulation in vitro is of great interest as it depicts the ability of this vaccine strategy to 
elicit both mucosal and systemic protective immune responses.  Indeed, immunization of 
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mice with mAb-iFt ICs increased the expression of MHC class II and co-stimulatory 
molecules (B7.1 and B7.2) on the surface of lung DCs in vivo, hence facilitating a more 
robust antigen presentation to T lymphocytes and subsequent generation of memory.  It is 
believed the activation of lung DCs is a direct effect of FcγR targeting and is not aided by 
the LPS present in the bacterial cell wall.  This is evident due to the significant 
differences in DCs maturation between the iFt and mAb-iFt immunized mice.  In 
addition, F. tularensis LPS is structurally different from other enteric LPS and has 
reduced stimulatory effect on APCs (Ancuta et al. 1996; Duenas et al., 2006).   
Although it is clear that memory T cells can be distinguished into central and 
effector subtypes, their relevance during recall responses has been controversial.  Central 
memory (CM) T cells usually reside in the secondary lymphoid tissues due to their high 
expression of CD62L and CCR7.  Effector memory (EM) T cells on the other hand, have 
a greater capacity to migrate to inflamed tissues, partly due to increased expression of 
chemokine receptors, such as CCR2 and CCR5 (Gunn et al., 1998; Sallusto et al., 1999 
(a); Campbell & Butcher, 2000; Kaech et al., 2002; Esser et al., 2003; McKinstry et al., 
2010).  Generation of memory lymphocytes is often used to assess vaccination strategies, 
especially against intracellular pathogens. It has been previously shown that 
immunization with mAb-iFt immune complexes provides protection against F. tularensis 
infection 30 days post-immunization, indicating that targeting of bacterial antigens to 
FcγR results in the generation of protective memory lymphocytes (Rawool et al., 2008).  
The lack of an increased CM T cell population though following FcR targeting, was 
surprising.  Perhaps the significant enhancement of EM T cells during F. tularensis LVS 
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infection is of vital importance for the protection observed in animal model used in this 
study.  Indeed, it has been shown that at early stages after bacterial infection, effector 
cells dominate the memory pool and provide potent protective immunity (Roberts et al., 
2005).   
The origin of the EM CD4
+
 T cells in the current study remains unclear.  One 
possibility is that these cells were generated in the secondary lymphoid organs, such as 
spleen and lymph nodes, and homed to the lungs early, after F. tularensis LVS challenge, 
possibly in a chemokine-dependent manner.  Alternatively, the EM T cells may have 
been generated locally, from the central memory pool.  Indeed, in an elegant study from 
Blander et al., (2003), use of a transgenic T cell line showed that a significant percentage 
of CM T lymphocytes can acquire effector functions upon re-stimulation (Blander et al., 
2003).  Although the levels of CM T cells in the lungs and spleens of IC immunized mice 
were not different from the levels observed in mice immunized with iFt alone, it is 
speculated that the differences at the post-immunization stage are qualitative.  It is likely 
that the enhanced activation status of DCs enable them to generate CM T cells that are 
more effectively programmed to switch to an effector memory phenotype during 
infection, both in the mucosa and systemically.  Therefore, it is clear that the ability of 
vaccines to induce EM T cells is a requirement for protection.  In addition, generation of 
EM cells in the secondary lymphoid organs requires prolonged and systemic exposure of 
the immunogen which often poses a challenge, especially for non-replicative vaccine 
vectors.  It is possible that targeting iFt to FcR aids the widespread distribution of 
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antigen, increasing the number of antigen encounters by naïve T cells and thus 
circumventing this problem. 
Currently it is not certain whether the EM CD4
+
 T cells are independently capable 
to provide protection against pulmonary infection with F. tularensis.  Previous studies 
have implicated both CD4
+ 
and CD8
+
 T cell subtypes in protection against this mucosal 
pathogen as neutralization of either CD4
+
 or CD8
+
 T cells in vivo was not detrimental to 
the host (Conlan et al., 1994; Yee et al., 1996).  One can assume that protection mediated 
by CD4
+
 T cells is mainly IFN-γ dependent while the cytotoxic effects of CD8+ T 
lymphocytes will be important in clearing the infection.  The independent protective role 
of CD4
+
 T cells in the model used is currently under investigation via adoptive transfer 
experiments, while the effect of mAb-iFt IC immunization on the generation of CD8
+
 
memory T lymphocytes is also currently being studied. 
Another aspect to be considered in vaccine design is the maintenance of effector 
memory cells. Apart from persistence of the immunogen, the cytokine milieu may 
mediate the long-term survival of these memory cells.  More specifically, Esser et al., 
(2003), suggested that IL-12 may be a candidate factor to maintain CD4
+ 
memory cells 
(Esser et al., 2003).  In addition, IL-12 has been shown to enhance the potency and 
increase the durability of a leishmanial protein vaccine in mice (Gurunathan et al., 1998).  
In this study, IL-12 was necessary in protection against lethal F. tularensis LVS 
challenge as well as for generating EM CD4
+
 T cells.  This is in accordance with 
previous studies showing that both subunits of IL-12 (p35 and p40) are essential in 
resolving pulmonary F. tularensis infection while the administration of recombinant IL-
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12 i.n. facilitates bacterial clearance from the lungs of infected mice (Elkins et al., 2002; 
Pammit et al., 2004; Duckett et al., 2005).  Therefore, it is likely that targeting iFt to 
FcR on DCs (and potentially macrophages as well) increases the levels of IL-12 in vivo 
which drives EM T cell differentiation that is long-lived and displays Th-1-phenotype 
characteristics.  In the current model, EM CD4
+ 
T cells from IC immunized mice had 
higher frequency as well as increased ability to secrete IFN- compared to cells obtained 
from mice immunized with iFt alone, upon in vitro re-stimulation with F. tularensis LVS.  
It is believed that the CD4
+
 EM T-lymphocytes generated in this vaccine platform are 
also long lived as significant populations of these cells were still detectable 25 days post 
F. tularensis LVS challenge.  The presence of IFN-γ in the memory CD4+ T lymphocytes 
following in vitro re-stimulation with F. tularensis LVS indicates specificity against F. 
tularensis.  Enhanced production of IFN-γ in vivo can activate macrophages thus 
facilitating bacterial clearance while driving the switch towards Th-1 like antibody 
isotypes, such as IgG2a or IgG2c.  Indeed, a Th-1 like antibody response against F. 
tularensis has been previously shown following targeting of bacterial antigens to FcγR 
(Rawool et al., 2008).  Hence, these observations indicate that FcR targeting mediates 
Th-1 polarization of EM T lymphocytes through IL-12 secretion, while it generates a 
greater frequency of antigen-specific memory T cells.  The lack of protection against 
lethal F. tularensis LVS challenge following immunization of IFN- deficient mice with 
mAb-iFt IC (Rawool et al., 2008), leads to conclusion that the ability of EM T cells to 
produce IFN- may be indispensable for protection in this immunization model.  
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The specific F. tularensis responses observed in this study also revealed a CD4
-
 
cell population that expressed IFN-γ during re-stimulation with F. tularensis LVS in 
vitro.  This population had higher frequency in the mAb-iFt immunized mice, suggesting 
a memory recall response, but surprisingly these cells were not CD8
+
 T lymphocytes 
either.  Nevertheless, the potential CD8-mediated mechanisms are currently under 
investigation. 
It has been  previously shown that targeting of the fixed immunogen, iFt, to FcγR 
provided 20-50% protection in C57BL/6 mice against the more lethal F. tularensis strain, 
SchuS4 (Rawool et al., 2008).  It would be of interest to investigate whether SchuS4 
infection generates similar cellular immune responses, although the partial protection 
observed against this strain would account for more subtle differences among the 
immunized groups.  For this reason, the current study focused primarily on F. tularensis 
LVS model, although the analysis of cell mediated mechanisms involved in SchuS4 
protection is in the future scope of studies. 
In summary, the present work advances our understanding of the in vivo 
protective mechanisms involved following FcγR targeting of a fixed bacterial 
immunogen.  For the first time it is demonstrated that targeting of inactivated F. 
tularensis bacteria to FcγRs reverses the potential detrimental effect of IL-10 during the 
early stages of F. tularensis infection.  The anti-inflammatory cytokine IL-10 secreted by 
F. tularensis infected murine macrophages promotes the bacterial survival and replication 
by suppressing the synthesis of pro-inflammatory cytokines TNF-α, IL-12, IL-6 and IFN-
γ.  The immunization of mice with mAb-iFt triggers activation of macrophages, shifts the 
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cytokine profile from anti-inflammatory towards pro-inflammatory and alters 
macrophage activation state from alternatively activated to classically activated 
macrophages.  Intranasal immunization of mice with mAb-iFt IC increases the frequency 
of activated DCs as well as the generation of F. tularensis-specific, IFN- secreting, EM 
CD4
+
 T cells.  Generation and maintenance of the EM T cell population is dependent 
upon IL-12 that is partially produced by activated lung DCs, but also systemically by 
other professional APCs.  It is thought that the enhanced ability of the EM T cells to 
secrete IFN- is necessary for protection against F. tularensis challenge.  
These findings support the hypothesis that targeting bacterial immunogens to 
FcγRs on antigen presenting cells is an effective way to enhance innate immunity against 
intracellular pathogens during the early stages of infection.  In addition, this is the first 
study that implicates FcR in modulating DC and T cell responses in an infectious model 
in vivo, essentially bridging the innate and adaptive branch of the immune system.  The 
enhanced cellular immune responses in the lungs and spleen of immunized mice observed 
in this model provide evidence for the generation of pathogen-specific mucosal and 
systemic immunity.  Additional studies using the virulent type A F. tularensis SchuS4 
strain will enhance our understanding of the pathogenesis and evasion mechanisms of F. 
tularensis.  This targeting approach is highly applicable and promising as it fills a 
significant gap left by the paucity of FDA approved adjuvants and the lack of effective 
vaccines against mucosal pathogens. 
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